Literature DB >> 34818177

Monotherapy for nonvalvular A-fib with stable CAD?

Thomas P Garigan1, John S Earwood1, Michal Poplawski1.   

Abstract

A meta-analysis found oral anticoagulant (OAC) monotherapy provided efficacy comparable to OAC plus single antiplatelet therapy-with lower bleeding risk.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34818177      PMCID： PMC8619808          DOI： 10.12788/jfp.0289

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  8 in total

1.  2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Dharam J Kumbhani; Christopher P Cannon; Craig J Beavers; Deepak L Bhatt; Adam Cuker; Ty J Gluckman; Joseph E Marine; Roxana Mehran; Steven R Messe; Nimesh S Patel; Benjamin E Peterson; Kenneth Rosenfield; Sarah A Spinler; Vinod H Thourani
Journal:  J Am Coll Cardiol       Date:  2020-11-26       Impact factor: 24.094

2.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Stephan D Fihn; Julius M Gardin; Jonathan Abrams; Kathleen Berra; James C Blankenship; Apostolos P Dallas; Pamela S Douglas; Joanne M Foody; Thomas C Gerber; Alan L Hinderliter; Spencer B King; Paul D Kligfield; Harlan M Krumholz; Raymond Y K Kwong; Michael J Lim; Jane A Linderbaum; Michael J Mack; Mark A Munger; Richard L Prager; Joseph F Sabik; Leslee J Shaw; Joanna D Sikkema; Craig R Smith; Sidney C Smith; John A Spertus; Sankey V Williams
Journal:  J Am Coll Cardiol       Date:  2012-11-19       Impact factor: 24.094

3.  Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.

Authors:  Satoshi Yasuda; Koichi Kaikita; Masaharu Akao; Junya Ako; Tetsuya Matoba; Masato Nakamura; Katsumi Miyauchi; Nobuhisa Hagiwara; Kazuo Kimura; Atsushi Hirayama; Kunihiko Matsui; Hisao Ogawa
Journal:  N Engl J Med       Date:  2019-09-02       Impact factor: 91.245

4.  Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial.

Authors:  Natalia C Berry; Laura Mauri; Philippe Gabriel Steg; Deepak L Bhatt; Stefan H Hohnloser; Matias Nordaby; Corinna Miede; Takeshi Kimura; Gregory Y H Lip; Jonas Oldgren; Jurriën M Ten Berg; Christopher P Cannon
Journal:  Circ Cardiovasc Interv       Date:  2020-04-07       Impact factor: 6.546

5.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

Authors:  S Schulman; C Kearon
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

6.  Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.

Authors:  So-Ryoung Lee; Tae-Min Rhee; Do-Yoon Kang; Eue-Keun Choi; Seil Oh; Gregory Y H Lip
Journal:  Am J Cardiol       Date:  2019-06-25       Impact factor: 2.778

Review 7.  Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Brittany U Burda; Selvi B Williams; Janelle M Guirguis-Blake; Corinne V Evans
Journal:  Ann Intern Med       Date:  2016-04-12       Impact factor: 25.391

8.  Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.

Authors:  John J McNeil; Mark R Nelson; Robyn L Woods; Jessica E Lockery; Rory Wolfe; Christopher M Reid; Brenda Kirpach; Raj C Shah; Diane G Ives; Elsdon Storey; Joanne Ryan; Andrew M Tonkin; Anne B Newman; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Geoffrey A Donnan; Peter Gibbs; Colin I Johnston; Barbara Radziszewska; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.